Fundraising Fox
Myricx Bio
London, GB · 38 employees on LinkedIn · 4 known investors
Find your way into Myricx Bio
Sign up to find every way you can get introduced to Myricx Bio
- Your email: who you already know at Myricx Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Myricx Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment. The company focuses on discovering novel payloads to address unmet oncology needs.
Investors · 4
How we know: Brandon Capital Partners's portfolio page · Not right? Tell us
How we know: Novo Holdings's portfolio page · funding news · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJul 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Myricx Bio do?
- Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment. The company focuses on discovering novel payloads to address unmet oncology needs.
- Who are Myricx Bio's investors?
- Myricx Bio's investors include Brandon Capital Partners, Novo Holdings, Sofinnova Partners, Abingworth.
- Where is Myricx Bio headquartered?
- Myricx Bio is headquartered in London, GB.